News

Filter

Current filters:

None

55 to 64 of 97856 results

Intas becomes first Indian company to launch biosimilar in the EU

Intas becomes first Indian company to launch biosimilar in the EU

23-02-2015

Indian biopharma company Intas has become the first Indian company to launch a biosimilar in highly regulated…

BiosimilarsBiotechnologyFilgrastimHematologyImmunologicalsIndiaIntas PharmaceuticalsMarkets & MarketingRegulation

Russia’s Biocad to invest $120 million in expansion of domestic operations

23-02-2015

Biocad, one of Russia’s largest biotech companies, has officially announced its plans to invest up…

AvastinBiocadBiosimilarsBiotechnologyFinancialHerceptinOncologyProductionRocheRussia

Advagraf plus basiliximab results in significantly better renal function

23-02-2015

Data published last week in the American Journal of Transplantation demonstrate that in liver transplant…

AdvagrafAstellas PharmaBasiliximabNephrology and HepatologyPharmaceuticalResearch

Foundation Medicine and H3 Biomedicine announce oncology collaboration

Foundation Medicine and H3 Biomedicine announce oncology collaboration

23-02-2015

USA-based Foundation Medicine and privately-held US biopharma company H3 Biomedicine have announced a…

BiotechnologyFoundation MedicineH3 BiomedicineOncologyResearchUSA

FDA accepts for review Synageva's Biologics License Application for Kanuma

FDA accepts for review Synageva's Biologics License Application for Kanuma

23-02-2015

The US Food and Drug Administration has accepted for review the Biologics License Application for Kanuma…

BiotechnologyGeneticsKanumaRegulationSynageva BioPharmaUSA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

Cyclenium signs drug discovery and collaboration agreement with Fundación MEDINA

23-02-2015

Emerging pharma company Cyclenium, focused on proprietary macrocyclic chemistry, has signed a drug discovery…

Antibiotics and Infectious diseasesBiotechnologyCycleniumFundacion MEDINAResearchSpain

Sosei acquires Heptares Therapeutics for up to $400 million

Sosei acquires Heptares Therapeutics for up to $400 million

23-02-2015

Japanese drugmaker Sosei Group says it has acquired Heptares Therapeutics, a clinical-stage private UK-based…

BiotechnologyHeptares TherapeuticsMergers & AcquisitionsNeurologicalRare diseasesSosei

Valeant fourth-qtr 2014 earnings beat expectations

Valeant fourth-qtr 2014 earnings beat expectations

23-02-2015

Canada’s Valeant Pharmaceutical International posted financial results late Sunday, showing that fourth-quarter…

FinancialPharmaceuticalValeantValeant Pharmaceutical InternationalValeant Pharmaceuticals International

Roche likely to lose another state contract in Russia

Roche likely to lose another state contract in Russia

23-02-2015

Swiss pharma giant Roche will probably lose one of its major contracts in Russia for the next several…

AvastinBiocadBiosimilarsBiotechnologyMarkets & MarketingOncologyRocheRussia

55 to 64 of 97856 results

COMPANY SPOTLIGHT

Menarini

Back to top